Derivation of HLA-A11/Kb Transgenic Mice: Functional CTL Repertoire and Recognition of Human A11-Restricted CTL Epitopes

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4753-4761

  Alexander, Jeff ^a   Oseroff, Carla ^a   Sidney, John ^a   Wentworth, Peggy ^a   Keogh, Elissa ^a   Hermanson, Gary ^b   Chisari, Francis V ^b   Kubo, Ralph T ^a   Grey, Howard M ^c   Sette, Alessandro ^a  

^a CYTEL CORPORATION   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; H2 ANTIGEN; HLA A ANTIGEN; HLA A11; HLA-A11; HYBRID PROTEIN; PEPTIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PROTEIN BINDING; SPECIES DIFFERENCE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; H-2 ANTIGENS; HLA-A ANTIGENS; HUMANS; INFLUENZA A VIRUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES;

EID: 0031573132     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
2. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
3. Germain, M. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
4. Bevan, M. J. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639.
5. Goldberg, A., and K. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375.
6. Monaco, J. J. 1992. A molecular model of MHC class-I-restricted antigen processing. Immunol. Today 13:173.
7. Howard, J. C., and A. Seelig. 1993. Antigen processing: peptides and the proteasome. Nature 365:21.
8. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
9. Eggers, M., B. Boes-Fabian, T. Ruppert, P.-M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865.
10. Koopmann, J.-O., G. J. Hämmerling, and F. Momburg. 1997. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9:80.
11. Townsend, A., and J. Trowsdale. 1993. The transporters associated with antigen presentation. Semin. Cell Biol. 4:53.
12. Neefjes, J. J., F. Momburg, and G. J. Hämmerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
13. Androlewicz, M. J., K. S. Anderson, and P. Cresswell. 1993. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA 90:9130.
14. Shepherd, J. C., T. N. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, and S. Tonegawa. 1993. TAP1-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 74:577.
15. van Endert, P. M., R. Tampe, T. H. Meyer, R. Tisch, J.-F. Bach, and H. O. McDevitt. 1994. A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1:491.
16. Heemels, M.-T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
17. Lehner, P. J., and P. Cresswell. 1996. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:59.
18. Androlewicz, M. J., and P. Cresswell. 1996. How selective is the transporter associated with antigen processing? Immunity 5:1.
19. Androlewicz, M. J., and P. Cresswell. 1994. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1:7.
20. Momburg, F., J. Roelse, G. J. Hämmerling, and J. J. Neefjes. 1994. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179:1613.
21. Koopman, J.-O., M. Post, J. J. Neefjes, G. J. Hämmerling, and F. Momburg. 1996. Translocation of long peptides by transporters associated with antigen processing (TAP). Eur. J. Immunol. 26:1720.
22. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hämmerling, and J. J. Neefjes. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648.
23. Heemels, M.-T, T. N. M. Schumacher, K. Wonigeit, and H. L. Ploegh. 1993. Peptide translocation by variants of the transporter associated with antigen processing. Science 262:2059.
24. Schumacher, T. N. M., D. V. Kantesaria, M. T. Heemels, P. G. Ashton-Rickardt, J. C. Shepherd, K. Fruh, Y. Yang, P. A. Peterson, S. Tonegawa, and H. L. Ploegh. 1994. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179:533.
25. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
26. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted Influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007.
27. Wentworth, P. A., A. Vitiello, J. Sidney, E. Keogh, R. W. Chesnut, H. Grey, and A. Sette. 1996. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26:97.
28. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M.-F. del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
29. + influenza matrix peptide in human MHC class I transgenic mice. J. Immunol. 153:4458.
30. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733.
31. Vitiello, A., A. Sette, L. Yuan, P. Farness, S. Southwood, J. Sidney, R. W. Chesnut, H. M. Grey, and B. Livingston. 1997. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance. Eur. J. Immunol. 27:671.
32. Fernandez-Vina, M. A., M. Falco, Y. Sun, and P. Stastny. 1992. DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of-A28. Hum. Immunol. 33:163.
33. Krausa, P., M. Brywka III, D. Savage, K. M. Hui, M. Bunce, J. L. F. Ngai, L. L. T. Teo, Y. W. Ong, D. Barouch, C E. M. Allsop, A. V. S. Hill, A. J. McMichael, J. G. Bodmer, and M. J. Browning. 1995. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 45:223.
34. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobori. 1992. Allele and haplotype frequencies tor HLA and complement loci in various ethnic groups. In HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol 1. K. Tsuji, M. Aizaqa, and T. Sasazuki, eds. Tokyo, Oxford University Press, pp. 1065-1074.
35. Zhang, Q.-J., R. Gavioli, G. Klein, and M. G. Masucci. 1993. An HLA-A11-specitic motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA 90:2217.
36. Kubo, R. T., A. Sette, H. M. Grey, E. Appella, K. Sakaguchi, N.-Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, W. M. Bodnar, T. A. Davis, and D. F. Hunt. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913.
37. Falk, K., O. Rötzschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31, -A31, and -A33 molecules. Immunogenetics 40:238.
38. Sidney, J., H. M. Grey, S. Southwood, E. Celis, P. A. Wentworth, M.-F. del Guercio, R. T. Kubo, R. W. Chesnut, and A. Sette. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:79.
39. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17:261.
40. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
41. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C null human cell line. J. Immunol. 142:3320.
42. Kriegler, M. 1991. PCR-based expression. In Gene Transfer and Expression. W. H. Freeman and Co., NY, pp. 165-172.
43. Hogan, G., F. Constantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Habor, NY.
44. Malissen, B., and N. Rebai. 1983. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22:107.
45. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
46. Milich, D. R., J. L. Hughes, A. McLachlan, G. B. Thornton, and A. Moriarty. 1989. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl. Acad. Sci. USA 85:1610.
47. Ressing, M. E., W. J. van Driel, E. Celis, A. Sette, R. M. P. Brandt, M. Hartman, J. D. H. Anholts, G. M. T. Schreuder, W. B. ter Harmsel, G. J. Fleuren, B. J. Trimbos, W. M. Kast, and C. J. M. Melief. 1996. Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope. Cancer Res. 56:582.
48. Wentworth, P. A., E. Celis, C. Crimi, S. Stitely, L. Hale, V. Tsai, H. M. Serra, M.-F. del Guercio, B. Livingston, D. Alazard, J. Fikes, R. T. Kubo, H. M. Grey, R. W. Chesnut, F. V. Chisari, and A. Sette. 1995. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol. 32:603.
49. + T cells in the central region of the HIV-1 nef protein. J. Immunol. 146:1560.
50. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514.
51. Johnson, R. P., and B. D. Walker. 1991. Identification of HIV-1 cytotoxic T-lymphocyte epitopes and implications for vaccine development. Biotechnol. Ther. 2:137.
52. Gavioli, F., M. G. Kurilla, P. O. de Campos-Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572.
53. Achour, A., B. Begue, E. Gomard, P. Paul, B. Sayagh, A. Van Pel, and J.-P. Levy. 1986. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Eur. J. Immunol. 16:597.
54. Maier, R., K. Falk, O. Rotzschke, B. Maier, V. Gnau, S. Stevanovic, G. Jung, H.-G. Rammensee, and A. Meyerhans. 1994. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306.
55. + T cells. Cell 71:1205.
56. 2-microglubulin mutant mice. Eur. J. Immunol. 25:174.
57. + T cell repertoire that displays both diversity and peptide specificity. Eur. J. Immunol. 26:288.
58. Falk, L., O. Rötzschke, and H. G. Rammensee. 1990. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248.
59. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
60. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
61. Roelse, J., M. Gromme, F. Momburg, G. Hämmerling, and J. J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591.